vatalanib has been researched along with Cancer of Colon in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, LW; Lin, G; Poon, DC; To, KK; Wang, F; Wei, Y | 1 |
| Borner, MM | 1 |
| Hoff, PM | 1 |
| Bodis, S; Fabbro, D; Glanzmann, C; Hegyi, I; Hess, C; Pruschy, M; Riesterer, O; Vuong, V; Wood, J | 1 |
1 review(s) available for vatalanib and Cancer of Colon
| Article | Year |
|---|---|
[Molecular targets in colon cancer].
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Camptothecin; Cetuximab; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Drug Delivery Systems; ErbB Receptors; Gefitinib; Humans; Imatinib Mesylate; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolones; Receptors, Platelet-Derived Growth Factor; Receptors, Somatomedin; Signal Transduction; Sirolimus; Sunitinib | 2006 |
3 other study(ies) available for vatalanib and Cancer of Colon
| Article | Year |
|---|---|
Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HEK293 Cells; Humans; Irinotecan; Isoenzymes; Neoplasm Proteins; Phthalazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins | 2015 |
Novel agents and targets for the therapy of advanced colon cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Colonic Neoplasms; Humans; Neoplasm Staging; Phthalazines; Protein Kinase Inhibitors; Pyridines | 2007 |
Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth.
Topics: Adenocarcinoma; Administration, Oral; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Division; Colonic Neoplasms; Combined Modality Therapy; Endothelium, Vascular; Enzyme Inhibitors; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neovascularization, Pathologic; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Radiotherapy, Adjuvant; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays | 2001 |